Iovance Biotherapeutics
IOVA
#6100
Rank
โ‚น82.66 B
Marketcap
โ‚น208.23
Share price
5.00%
Change (1 day)
-72.49%
Change (1 year)

Market capitalization of Iovance Biotherapeutics (IOVA)

Market cap: โ‚น82.66 Billion

As of December 2025 Iovance Biotherapeutics has a market cap of โ‚น82.66 Billion. This makes Iovance Biotherapeutics the world's 6100th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Iovance Biotherapeutics from 2010 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น82.66 B-57.1%
2024โ‚น192.69 B11.25%
2023โ‚น173.20 B107.58%
2022โ‚น83.44 B-62.57%
2021โ‚น222.93 B-55.21%
2020โ‚น497.77 B99.49%
2019โ‚น249.52 B226.72%
2018โ‚น76.37 B105.85%
2017โ‚น37.10 B26.29%
2016โ‚น29.37 B17.95%
2015โ‚น24.90 B47.95%
2014โ‚น16.83 B29.6%
2013โ‚น12.98 B1223.59%
2012โ‚น0.98 B-76.52%
2011โ‚น4.17 B5.53%
2010โ‚น3.95 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Iovance Biotherapeutics was reported to be:

โ‚น82.66 Billion
by Nasdaq info icon info icon
โ‚น82.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NRC Health
NRC
โ‚น32.95 B-60.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
โ‚น1.64 B-98.01% Bahamas